SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-056637
Filing Date
2023-05-05
Accepted
2023-05-05 17:15:20
Documents
16
Period of Report
2023-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314833d1_8k.htm   iXBRL 8-K 40395
2 EXHIBIT 1.1 tm2314833d1_ex1-1.htm EX-1.1 223439
3 EXHIBIT 5.1 tm2314833d1_ex5-1.htm EX-5.1 6414
4 EXHIBIT 99.1 tm2314833d1_ex99-1.htm EX-99.1 6088
8 GRAPHIC tm2314833d1_ex5-1img001.jpg GRAPHIC 3315
  Complete submission text file 0001104659-23-056637.txt   517103

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA imgn-20230504.xsd EX-101.SCH 3036
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20230504_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20230504_pre.xml EX-101.PRE 22597
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2314833d1_8k_htm.xml XML 3464
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 23894974
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences